Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Macrogenics Inc (MGNX)  
$14.56 0.19 (1.32%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,030,000
Market Cap: 903.16(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.48 - $21.47
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MacroGenics is a biopharmaceutical company. Co.'s main pipeline program is MGC018, an antibody-drug conjugate that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. Co. is also developing enoblituzumab, an Fc-optimized monoclonal antibody that targets B7-H3 and molecules that target programmed cell death protein 1, a protein that is important in the regulation of the immune system's response to cancer. In addition, Co. is developing MGD024, a bispecific DART molecule that engages CD3 on immune effector cells to kill CD123-expressing cancer cells in certain hematological malignancies, including acute myeloid leukemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 350,000 2,394,399
Total Buy Value $0 $0 $1,722,425 $11,462,434
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 2 11
Total Shares Sold 261,204 293,400 293,400 298,772
Total Sell Value $4,645,136 $4,995,238 $4,995,238 $5,027,631
Total People Sold 5 5 5 5
Total Sell Transactions 9 11 11 12
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 286
  Page 9 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Risser Eric Blasius SVP, Business Development   •       –      –    2015-12-23 4 OE $0.94 $1,410 D/D 1,500 1,500     -
   Cilinski Lynn VP, Controller and Treasurer   •       –      –    2015-11-23 4 AS $35.00 $242,235 D/D (6,921) 1,923     -
   Cilinski Lynn VP, Controller and Treasurer   •       –      –    2015-11-23 4 OE $0.94 $1,114 D/D 1,185 5,029     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-11-16 4 AS $31.44 $97,998 D/D (3,117) 70,317     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-10-15 4 AS $25.21 $157,134 D/D (6,233) 73,434     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-10-13 4 OE $25.53 $370,721 D/D 14,521 79,667     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-10-13 4 OE $0.71 $10,310 D/D 14,521 94,188     -
   Karrels James SVP, CFO and Secretary   •       –      –    2015-10-07 4 OE $0.94 $5,640 D/D 6,000 10,100     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-10-02 4 OE $0.94 $16,804 D/D 17,877 79,667     -
   Wigginton Jon Marc Sr VP, Clinical   •       –      –    2015-10-01 4 AS $21.11 $105,550 D/D (5,000) 0     -
   Wigginton Jon Marc Sr VP, Clinical   •       –      –    2015-10-01 4 OE $4.70 $23,500 D/D 5,000 5,000     -
   Bonvini Ezio Sr VP, Research & CSO   •       –      –    2015-09-22 5 A $0.00 $0 I/I 7,550 7,550     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-09-22 5 GD $0.00 $0 D/D 7,550 76,083     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-09-18 4 OE $0.94 $6,580 D/D 7,000 61,790     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-09-16 4 OE $0.94 $3,760 D/D 4,000 54,790     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-08-27 4 OE $0.94 $4,700 D/D 5,000 50,790     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-08-26 4 OE $0.94 $4,700 D/D 5,000 45,790     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-08-10 4 OE $0.94 $3,760 D/D 4,000 40,790     -
   Wigginton Jon Marc Sr VP, Clinical   •       –      –    2015-08-03 4 AS $37.15 $371,500 D/D (10,000) 0     -
   Wigginton Jon Marc Sr VP, Clinical   •       –      –    2015-08-03 4 OE $4.70 $47,000 D/D 10,000 10,000     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-07-10 4 AS $38.09 $91,416 D/D (2,400) 36,790     -
   Bonvini Ezio Senior VP, Research   •       –      –    2015-07-10 4 OE $0.71 $1,704 D/D 2,400 39,190     -
   Cilinski Lynn VP, Controller and Treasurer   •       –      –    2015-07-01 4 OE $0.94 $3,586 D/D 3,815 7,659     -
   Wigginton Jon Marc Sr VP, Clinical   •       –      –    2015-07-01 4 AS $37.15 $185,750 D/D (5,000) 0     -
   Wigginton Jon Marc Sr VP, Clinical   •       –      –    2015-07-01 4 OE $4.70 $23,500 D/D 5,000 5,000     -
  286 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us